Is the Mortality Benefit With Empagliflozin in Type 2 Diabetes Mellitus Too Good To Be True?
作者信息
Kaul Sanjay
机构信息
From Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA.
出版信息
Circulation. 2016 Jul 12;134(2):94-6. doi: 10.1161/CIRCULATIONAHA.116.022537.
Abstract
摘要
Zotero 插件